Neurofibromatosis type 2: Growth stimulation of mixed acoustic schwannoma by concurrent adjacent meningioma: Possible role of growth factors. Case report

Journal of Neurosurgery

Volumn 89, Issue 1, 1998, Pages 149-154

  Pallini, Roberto ^a   Tancredi, Angelo ^b   Casalbore, Patrizia ^b   Mercanti, Delio ^b   Larocca, Luigi M ^b   Consales, Alessandro ^b   Lauretti, Liverana ^b   Fernandez, Eduardo ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE

Author keywords

Acoustic schwannoma; Cerebrospinal fluid; Epidermal growth factor; Meningothelial cells; Mixed tumor; Neurofibromatosis

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN PS2;

ACOUSTIC NEURINOMA; ADOLESCENT; ARTICLE; CASE REPORT; DIAGNOSTIC IMAGING; GROWTH RATE; GROWTH STIMULATION; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; MALE; MENINGIOMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0031859476     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1998.89.1.0149     Document Type: Article

References (59)

1. Adams EF, Schrell UMH, Fahlbusch R, et al: Hormonal dependency of cerebral meningiomas. Part 2: In vitro effect of steroids, bromocriptine, and epidermal growth factor on growth of meningiomas. J Neurosurg 73:750-755, 1990
2. Akutsu I, Aida T, Nakazawa S, et al: Localization of acidic and basic fibroblastic growth factor mRNA in human brain tumors. JPN J Cancer Res 82:1022-1027, 1991
3. Alemà S, Casalbore P, Agostini E, et al: Differentiation of PC12 phaeochromocytoma cells induced by v-src oncogene. Nature 316:557-559, 1985
4. Asai K, Hotta T, Nakanishi K, et al: Von Recklinghausen neurofibroma produces neuronal and glial growth-modulating factors. Brain Res 556:344-348, 1991
5. Bigorgne C, Thomine E, Hemet J, et al: [Benign glandular schwannoma and Recklinghausen disease. Report of a case.] Ann Pathol 12:114-120, 1992 (Fr)
6. Bijlsma EK, Brouwer-Mladin R, Bosch DA, et al: Molecular characterization of chromosome 22 deletions in schwannomas. Gen Chromosom Cancer 5:201-205, 1992
7. Brockes JB, Breakefield XO, Martuza RL: Glial growth factor-like activity in Schwann cell tumors. Ann Neurol 20:317-322, 1986
8. Brooks JS, Freeman M, Enterline HT: Malignant "Triton" tumors. Natural history and immunohistochemistry of nine new cases with literature review. Cancer 55:2543-2549, 1985
9. Charabi S, Thomsen J, Mantoni M, et al: Acoustic neuroma (vestibular schwannoma): growth and surgical and nonsurgical consequences of the wait-and-see policy. Otolaryngol Head Neck Surg 113:5-14, 1995
10. Cushing H, Eisenhardt L: Meningiomas. Their Classification, Regional Behaviour, Life History and Surgical End Results. Springfield, Ill: Charles C Thomas, 1938, pp 100-114
11. DiCarlo A, Mariano A, Macchia PE, et al: Epidermal growth factor receptor in human brain tumors. J Endocrinol Invest 15: 31-37, 1992
12. Eldridge R: Central neurofibromatosis with bilateral acoustic neuroma. Adv Neurol 29:57-65, 1981
13. Evans DG, Huson SM, Donnai D, et al: A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29:841-846, 1992
14. Feigin I: Mixed mesenchymal tumors: meningioma and nerve sheath tumors. J Neuropathol Exp Neurol 37:459-470, 1978
15. Fleming TP, Matsui T, Heidaran MA, et al: Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro. Oncogene 7:1355-1359, 1992
16. Geddes JF, Sutcliffe JC, King TT: Mixed cranial nerve tumors in neurofibromatosis type 2. Clin Neuropathol 14:310-313, 1995
17. Glover TW, Stein CK, Leguis E, et al: Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Gen Chromosom Cancer 3:62-70, 1991
18. Hawkins RA, Killen E, Whittle IR, et al: Epidermal growth factor receptors in intracranial and breast tumours: their clinical significance. Br J Cancer 63:553-560, 1991
19. Hermanson M, Funa K, Hartman M, et al: Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52:3213-3219, 1992
20. Hörstadius S: The Neural Crest. Its Properties and Derivatives in the Light of Experimental Research. Oxford: Oxford University Press, 1950
21. Jacoby LB, MacCollin M, Louis DN, et al: Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3:413-419, 1994
22. Kadono T, Soma Y, Takehara K, et al: The growth regulation of neurofibroma cells in neurofibromatosis type-1: increased responses to PDGF-BB and TGF-beta 1. Biochem Biophys Res Commun 198:827-834, 1994
23. Kanter WR, Eldridge R, Fabricant R, et al: Central neurofibromatosis with bilateral acoustic neurinoma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology 30:851-859, 1980
24. Kimura H: Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. Proc Natl Acad Sci USA 90:2165-2169, 1993
25. Kimura H, Fischer WH, Schubert D: Structure, expression and function of a schwannoma-derived growth factor. Nature 348: 257-260, 1990
26. Kimura H, Schubert D: Schwannoma-derived growth factor promotes the neuronal differentiation and survival of PC12 cells. J Cell Biol 116:777-783, 1992
27. Kousseff BG: The phakomatoses as paracrine growth disorders (paracrinopathies). Clin Genet 37:97-105, 1990
28. Laasonen EG, Troupp H: Volume growth rate of acoustic neuromas. Neuroradiology 28:203-207, 1986
29. Lichtor T, Kurpakus MA, Gurney ME: Expression of insulin-like growth factors and their receptors in human meningiomas. J Neurooncol 17:183-190, 1993
30. Linthicum FH Jr, Brackmann DE: Bilateral acoustic tumors. A diagnostic and surgical challenge. Arch Otolaryngol 106: 729-733, 1980
31. Mapstone T, McMichael M, Goldthwait D: Expression of platelet-derived growth factors, transforming growth factors, and the ros gene in variety of primary human brain tumors. Neurosurgery 28:216-222, 1991
32. Martuza RL, Eldridge R: Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 318:684-688, 1988
33. Murphy PR, Myal Y, Sato Y, et al: Elevated expression of basic fibroblastic growth factor messenger ribonucleic acid in acoustic neuromas. Mol Endocrinol 3:225-231, 1989
34. Nagashima C, Nakashio K, Fujino T: Meningioma and astrocytoma adjacent in the brain. J Neurosurg 20:995-999, 1963
35. Nager GT: Acoustic neurinomas. Acta Otolaryngol 99: 245-261, 1985
36. Nager GT: Acoustic neurinomas. Pathology and differential diagnosis. Acta Otolaryngol 89:252-279, 1969
37. Nager GT: Pathology of the Ear and Temporal Bone. Baltimore: Williams & Wilkins, 1993
38. Naguib MB, Saleh E, Aristegui M, et al: Decision making in acoustic neuroma management: the only hearing ear. Skull Base Surg 4:32-36, 1994
39. Ohmichi M, Decker SJ, Saltiel AR: Activation of phosphatidylinositol-3 kinase by nerve growth factor involves indirect coupling of the trk proto-oncogene with src homology 2 domains. Neuron 9:769-777, 1992
40. Ojemann RG, Martuza RL: Acoustic neuroma, in Youmans JR (ed): Neurological Surgery, ed 3. Philadelphia: WB Saunders, 1990, Vol 4, pp 3315-3350
41. Pensak ML, Tew JM, Keith RW, et al: Management of the acoustic neuroma in an only hearing ear. Skull Base Surg 1: 93-96, 1991
42. Rabin SJ, Cleghon V, Kaplan DR: SNT, a differentiation-specific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells. Mol Cell Biol 13:2203-2213, 1993
43. Rey JA, Pestana A, Bello MJ: Cytogenetics and molecular genetics of nervous system tumors. Oncol Res 4:321-331, 1992
44. Riccardi VM: Von Recklinghausen neurofibromatosis. N Engl J Med 305:1617-1627, 1981
45. Ross AH, Herlyn M, Maul GG, et al: The nerve growth factor receptor in normal and transformed neural crest cells. Ann NY Acad Sci 486:115-123, 1986
46. Rouleau GA, Seizinger BR, Wertelecki W, et al: Flanking markers bracket the neurofibromatosis type-2 (NF2) gene on chromosome 22. Am J Hum Genet 46:323-328, 1990
47. Rubenstein AE, Mytilineoau C, Yahr MD, et al: Neurological aspects of neurofibromatosis. Adv Neurol 29:11-21, 1981
48. Russell DS, Rubinstein LJR: Pathology of Tumours of the Nervous System. London: Arnold, 1989, p 501
49. Seizinger BR, Rouleau G, Ozelius LJ, et al: Common pathogenetic mechanisms for three tumor types in bilateral acoustic neurofibromatosis. Science 236:317-319, 1987
50. Shuangshoti S, Netsky MG: Neoplasms of mixed mesenchymal and neuroepithelial origin. Relation to "monstrocellular sarcoma" or "giant-celled glioblastoma." J Neuropathol Exp Neurol 30:290-309, 1971
51. Shuangshoti S, Netsky MG, Jane JA: Neoplasms of mixed mesenchymal and neuroepithelial type. With consideration of the relationship between meningioma and neurilemmoma. J Neurol Sci 14:277-291, 1971
52. Sporn MB, Todaro GJ: Autocrine secretion and malignant transformation of cells. N Engl J Med 303:878-880, 1980
53. Todo T, Adams EF, Fahlbusch R, et al: Autocrine growth stimulation of human meningioma by platelet-derived growth factor. J Neurosurg 84:852-859, 1996
54. Towbin H, Staehelin T, Fordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979
55. Twist EC, Ruttledge MH, Rousseau M, et al: The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147-151, 1994
56. Woodruff JM: Peripheral nerve tumors showing glandular differentiation (glandular schwannomas). Cancer 37:2399-2413, 1976
57. Worster-Drought C, Dickson WEC, McMenemey WH: Multiple meningeal and perineural tumors with analogous changes in the glia and ependyma (neurofibromatosis), with report of 2 cases. Brain 60:85-117, 1937
58. Yasuda T, Sobue G, Ito T, et al: Human peripheral nerve sheath neoplasm: expression of Schwann cell-related markers and their relation to malignant transformation. Muscle Nerve 14: 812-819, 1991
59. Yasuda T, Sobue G, Mitsuma T, et al: Nerve growth factor receptor immunoreactivity in human benign peripheral nerve sheath tumor. Acta Neuropathol 77:591-598, 1989